Orgenesis and ATMI partner in diabetes cell therapy Belgian subsidiary
Orgenesis has partnered ATMI and established a subsidiary in Belgium in order to manufacture cells for clinical trials of its insulin-producing regenerative drug.
Archives for November 8, 2013
Thermo Fisher awaits regulatory nod for Life Tech acquisition
Thermo Fisher has applied to the EU and New Zealand’s competition commissions for approval of its acquisition of Life Technologies.
ADC Therapeutics licenses proprietary antibodies from Five Prime
ADC Therapeutics and Five Prime Therapeutics have announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.